Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 48 - Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy
Patents for A61K 48 - Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy (86,964)
06/2010
06/09/2010CN101724041A Human epididymal expression sperm binding protein HEL-47 as well as encoding gene and application thereof
06/09/2010CN101724040A Human epididymal expression sperm binding protein HEL-44 as well as encoding gene and application thereof
06/09/2010CN101724039A Human epididymal expression sperm binding protein HEL-38 as well as encoding gene and application thereof
06/09/2010CN101724038A Human epididymis expression sperm binding protein HEL-5, encoding gene and application thereof
06/09/2010CN101724037A Human epididymis expression sperm binding protein HEL-6, encoding gene and application thereof
06/09/2010CN101724036A Human epididymal expression sperm binding protein HEL-45 as well as encoding gene and application thereof
06/09/2010CN101724035A Human epididymal expression sperm binding protein HEL-43 as well as encoding gene and application thereof
06/09/2010CN101724034A Human epididymal expression sperm binding protein HEL-40 as well as encoding gene and application thereof
06/09/2010CN101724033A Human epididymal expression sperm binding protein HEL-28 as well as encoding gene and application thereof
06/09/2010CN101724032A Human epididymis expression sperm binding protein HEL-9, encoding gene and application thereof
06/09/2010CN101721715A Compound of tumor targeted nonviral gene vector and plasmid DNA and preparation method thereof
06/09/2010CN101721711A Method for preparing phenanthroline ruthenium cyclodextrin-adamantane pyrene-single wall carbon nanometer pipe ternary ultramolecular system and application thereof
06/09/2010CN101721697A Anti-cancer and anti-infectious disease compositions and methods for using same
06/09/2010CN101280316B Therapeutic vaccine for human cervical carcinoma
06/08/2010US7732593 Useful in the design of improved RNAi-mediating agents which allow for more exact control of the efficacy of RNA silencing; enhancing silencing of a target mRNA
06/08/2010US7732588 Expression vector comprising nucleotide sequences coding tumor necrosis factor receptor protein (TWEAK) for mediated by angiogenesis, such as solid tumors and vascular deficiencies of cardiac or peripheral tissue
06/08/2010US7732584 Exhibits tissue specific expression in normal adult tissue, and is aberrantly expressed in cancers; provides a diagnostic, prognostic, prophylactic and/or therapeutic target for cancer
06/08/2010US7732576 for identification on human chromosome 10 of a tumor suppressor gene;
06/08/2010US7732423 Nucleotide vector, composition containing such vector, and vaccine for immunization against hepatitis
06/08/2010US7732422 TRPM-2 antisense therapy
06/08/2010US7732207 Method for expression of small antiviral RNA molecules within a cell
06/08/2010US7732203 Method for transdifferentiating mesenchymal stem cells into neuronal cells
06/08/2010US7732201 neural cells comprising a neuroblast and a nestin-positive neural cell; for treating neuronal disorders
06/08/2010US7732200 Using chondroitin sulfate proteoglycan (CSPG)-degrading enzymes mixture to propagate nervous system tissue in culture for use as tissue targeted tools in treatment of brain and neurodegenerative disorders
06/08/2010US7732193 Expressing preferential nucleotide sequences in cells; obtain cell, transfect, recover packaged retrovirus, infect target cell, monitor gene expression in cell
06/08/2010US7732129 use of low-medium perfusion rates in an attached cell culture system to provide for improved yields; improved Ad-p53 production with cells grown in serum-free conditions; offers scalability, validatability and virus purity comparable to that achieved using CsCl gradient ultracentrifugation
06/08/2010US7731967 Compositions for inducing immune responses
06/08/2010US7731959 Antagonists of neuropilin receptor function and use thereof
06/08/2010US7731952 Avirulent oncolytic herpes simplex virus strains engineered to counter the innate host response
06/08/2010US7731937 Diagnostic method for paratuberculosis
06/08/2010US7731653 System and method for genetically treating cardiac conduction disturbances
06/08/2010CA2368135C Xylo-lna analogues
06/08/2010CA2283684C Down-regulation of gene expression by colorectal administration of synthetic oligonucleotides
06/08/2010CA2266342C Packaging cell lines for use in facilitating the development of high-capacity adenoviral vectors
06/08/2010CA2210956C Method for preparing a recombinant adenovirus genome
06/03/2010WO2010062975A2 Suppressor of ap-1
06/03/2010WO2010062966A2 Methods for inducing mixed chimerism
06/03/2010WO2010062762A2 Compositions and methods for reducing the signs of aging of the skin
06/03/2010WO2010062322A2 Modulation of the immune response
06/03/2010WO2010061881A1 Oligoribonucleotide or peptide nucleic acid capable of inhibiting activity of hepatitis c virus
06/03/2010WO2010060934A2 Cnnm proteins and uses thereof
06/03/2010WO2010060430A2 Optimized influenza vaccines
06/03/2010WO2010060186A1 Antibodies that specifically block the biological activity of a tumor antigen
06/03/2010WO2010033560A3 Sur1 inhibitors for therapy
06/03/2010WO2010019276A3 Method and formulation for treating adverse biological conditions
06/03/2010WO2003006486A3 Bcr-abl oligomerization domain polypeptides and uses therefor
06/03/2010US20100137404 Compositions and Methods for Altering Gene Expression
06/03/2010US20100137210 Gastrointestinal proliferative foctor and uses thereof
06/03/2010US20100137205 Use of FGF-18 Protein, Target Proteins and Their Respective Encoding Nucleotide Sequences to Induce Cartilage Formation
06/03/2010US20100137196 Histone deacetylases, and uses related thereto
06/03/2010US20100136695 Double-stranded oligonucleotides
06/03/2010US20100136693 Mutants of Deoxycytidine Kinase Having Extended Enzymatic Activity
06/03/2010US20100136623 Mutations in ion channels
06/03/2010US20100136581 Diagnosis and treatment of malignant neoplasms
06/03/2010US20100136577 Compositions and methods for detection and treatment of proliferative abnormalities associated with overexpression of human transketolase like-1 gene
06/03/2010US20100136575 B7-related nucleic acids and polypeptides useful for immunomodulation
06/03/2010US20100136522 Endogenous retroviruses up-regulated in prostate cancer
06/03/2010US20100136101 Compositions and methods for sirna inhibition of hif-1 alpha
06/03/2010US20100136100 Removal promoters and inhibitor for apoptosis cells in vivo
06/03/2010US20100136056 Novel insertion sites in pox vectors
06/03/2010US20100136003 Uses of mammalian cytokine; related reagents
06/03/2010US20100135958 Method for treating cancer in humans
06/03/2010US20100135957 Chimeric Heteromultimer Adhesins
06/03/2010US20100135953 Method of treatment of age-related macular degeneration
06/03/2010CA2743824A1 Implantable ocular drug delivery device and methods
06/03/2010CA2740900A1 Antibodies that specifically block the biological activity of a tumor antigen
06/02/2010EP2192188A1 Anti-met monoclonal antibody, fragments and vectors thereof, for the treatment of tumors and corresponding products
06/02/2010EP2192128A2 Compounds and methods for treatment and diagnosis of chlamydial infection
06/02/2010EP2191000A1 Inflammation-induced anti-inflammatory gene expression
06/02/2010EP2190995A2 Compositions comprising k-ras sirna and methods of use
06/02/2010EP2190990A1 Pthrp, its isoforms and antagonist thereto in the diagnosis and treatment of disease
06/02/2010EP2190985A1 Cancer-related genes, cdca5, epha7, stk31 and wdhd1
06/02/2010EP2190483A1 Method of reducing the effects of cytostatic drugs on bone marrow derived cells, and methods of screening
06/02/2010EP1534736B1 Nogo receptor antagonists
06/02/2010CN1704123B Little interfered RNA preparation for internal preventing or curing respiratory system diseases and screening method thereof
06/02/2010CN1354755B Nucleotide and protein sequence of Nogo genes and methods based thereon
06/02/2010CN1291231B Human telomerase catalytic subunit
06/02/2010CN101720436A Methods and agents for inhibiting tumor growth by targeting the ssdna replication intermediate of tumor stem cells
06/02/2010CN101717779A Fusion protein suitable for anthrax antitoxin and vaccines
06/02/2010CN101716352A Antisense oligonucleotide nano preparation resisting middle-period factor, preparation and application thereof
06/02/2010CN101716351A Use of pyridine compound in preparation of RNA interference reinforcing agent
06/02/2010CN101716350A AIDS live carrier multipartial vaccine and construction method thereof
06/02/2010CN101716346A Supramolecular hydrogel gene vector material, and preparation method and application thereof
06/02/2010CN101716339A IL-12 and TNF-alpha autologous tumor vaccine
06/02/2010CN101716338A DNA vaccine for promoting regeneration and functional rehabilitation of nerves of central system
06/02/2010CN101338321B Method for constructing and screening miRNAs expression vector of stomach cancer target FUT3 gene and uses thereof
06/02/2010CN101275134B Medicament for curing breast carcinoma and special antisense oligonucleotide therefor
06/02/2010CN101148680B Method for introducing plasmid vector containing gene cure segment in cell by nano particles
06/01/2010US7727971 PlGF results in functional improvement of a skeletal muscle in a mammal after a skeletal muscle ischemic event
06/01/2010US7727970 Multiple promoter expression cassettes for simultaneous delivery of RNAi agents targeted to Hepatitis C virus
06/01/2010US7727969 Controlled release nanoparticle having bound oligonucleotide for targeted delivery
06/01/2010US7727757 For invoking an immune response, delaying the onset of AIDS in an animal exposed to infectious HIV
06/01/2010US7727712 Having an immunostimulatory sequence comprising the sequence 5'-C, G-3', wherein an HBV antigen is not administered in conjunction with administration of said nucleotide; for treatment of subject with hepatitis B virus
06/01/2010US7727543 Biodegradable carrier and method for preparation thereof
06/01/2010US7727536 EG-VEGF nucleic acids and polypeptides and methods of use
06/01/2010US7727534 Gentically engineered viral particles for use in targeted tumor destruction; Antitumor agents
06/01/2010US7727529 Hepatitis c viral E2 glycoprotein specific immunoglobulin for use in prevention and treatment of hepatitis infection
06/01/2010US7727522 Simian immunodeficiency retroviral vector for use efficient tool in heterologous gene transfer; improved exogenous gene expression; gene therapy
06/01/2010CA2424700C Genetic immunisation against cervical carcinoma
06/01/2010CA2358915C Modified hiv env polypeptides
1 ... 149 150 151 152 153 154 155 156 157 158 159 160 161 162 163 164 165 166 167 168 169 ... 870